4-(6-Hydroxy-benzothiazol-2-yl)-benzene-1,2-diol

ID: ALA295539

Chembl Id: CHEMBL295539

PubChem CID: 135526991

Max Phase: Preclinical

Molecular Formula: C13H9NO3S

Molecular Weight: 259.29

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Oc1ccc2nc(-c3ccc(O)c(O)c3)sc2c1

Standard InChI:  InChI=1S/C13H9NO3S/c15-8-2-3-9-12(6-8)18-13(14-9)7-1-4-10(16)11(17)5-7/h1-6,15-17H

Standard InChI Key:  MCKWUTRQXDCRFM-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA295539

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 259.29

Molecular Weight (Monoisotopic): 259.0303

AlogP: 3.08

#Rotatable Bonds: 1

Polar Surface Area: 73.58

Molecular Species: NEUTRAL

HBA: 5

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.59

CX Basic pKa: 2.31

CX LogP: 3.23

CX LogD: 3.20

Aromatic Rings: 3

Heavy Atoms: 18

QED Weighted: 0.59

Np Likeness Score: -0.74

References

1. Stevens MF, McCall CJ, Lelieveld P, Alexander P, Richter A, Davies DE..  (1994)  Structural studies on bioactive compounds. 23. Synthesis of polyhydroxylated 2-phenylbenzothiazoles and a comparison of their cytotoxicities and pharmacological properties with genistein and quercetin.,  37  (11): [PMID:8201603] [10.1021/jm00037a020]

Source

Source(1):

• Scientific Literature